MAM
Mudra Max conjures snowfall in Chennai for Apollo Munich
MUMBAI: Standalone health insurance company Apollo Munich in partnership with Mudra Max executed an event to promote the company‘s health insurance project by creating artificial snowfall at the Express Avenue Mall in Chennai.
The health insurance project named Optima Restore was launched with the proposition of ‘unbelievable‘ and snowfall in Chennai was part of the launch campaign. The pre-event hype promotion saw promoters distributing Apollo Munich branded balloons with ‘Snowfall in Chennai‘ written on it as an invite. Radio also acted as an invite medium to drive people in hordes to the event.
On the day of the event, the team created a maze structure through which people could explore their way to the main event to experience snowfall. A snow machine threw imitation snow around an igloo through the day attracting crowds. To complete the experience a motion sensing game played on the large screen was also installed.
Mudra Max (OOH, Experiential, Retail) president and head Mandeep Malhotra said, “For a mall event to reach out to more than 100,000 people over the weekend is rare. Needless to say, the brand delivered on its promise of offering the ‘Impossible‘ to the people of Chennai and am indeed happy that I was present here personally to experience the same.”
Apollo Munich Health Insurance CEO Antony Jacob said, “Optima Restore has two benefits. Restore benefit automatically reinstates the basic sum insured in case the insured exhausts their sum insured in a policy year. Another is the Multiplier benefit, where in case a customer have acclaim free year, the insurance cover increases by 50 per cent the next year and double it the year after at no extra change guaranteed. Optima Restore has been designed to offer complete comfort to health insurance consumers, since their coverage will increase whether they use up the plan, or don‘t use it at all. Guaranteed, and with no extra charge.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
